Isobel Finnie leads the life sciences and biotechnology team at Haseltine Lake Kempner, where her multidisciplinary practice embraces a wide variety of life science technologies, especially in the fields of biotechnology and biochemistry. She has developed considerable technical and professional expertise in the fields of cancer therapeutics and cancer pro-drugs, dermatology, biomarkers, diagnostics, vaccines, antibody-based therapeutics, stem cell technologies, DNA sequencing technologies and medical devices. Finnie uses her 20 years of experience to assist a range of SME clients who value her pragmatic, no-nonsense and commercially focused advice.